| Ytd | 12.33% | |
| 1y | 9.55% |
| Open | 18.95 | Prev Close | 18.99 | Low | 18.73 | High | 19.05 | Mkt Cap | 6.61B |
| Vol | 5.56M | Avg Vol | 3.78M | EPS | -0.26 | P/E | N/A | Forward P/E | 951.50 |
| Beta | 0.82 | Short Ratio | 4.37 | Inst. Own | 115.41% | Dividend | 0.96 | Div Yield | 5.06 |
| Ex Div Date | 08-11 | Earning | 10-29 | 50-d Avg | 20.32 | 200-d Avg | 18.71 | 1yr Est | 21.58 |
Healthcare Realty Trust (HR) has become technically an oversold stock now, which implies exhaustion
RBC Capital analyst Michael Carroll maintains Healthcare Realty Trust (NYSE:HR) with a Sector Per
Healthcare Realty Trust NYSE: HR reported second-quarter results marked by higher occupancy, leasing
Healthcare Realty Trust Incorporated (HR) Q2 2026 Earnings Call Transcript
Cantor Fitzgerald analyst Richard Anderson maintains Healthcare Realty Trust (NYSE:HR) with a Ove
Healthcare Realty Trust (HR) came out with quarterly funds from operations (FFO) of $0.41 per share,
Healthcare Realty Trust (NYSE:HR) reported quarterly earnings of $0.41 per share which beat the anal
Healthcare Realty Trust (NYSE:HR) raises FY2026 FFO guidance from $1.59-$1.65 to $1.62-$1.66 vs $1.6
NASHVILLE, Tenn., July 30, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) t
JP Morgan analyst Michael Mueller maintains Healthcare Realty Trust (NYSE:HR) with a Neutral and
NASHVILLE, Tenn., July 07, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) t
Raymond James analyst David Rodgers reinstates Healthcare Realty Trust (NYSE:HR) with a Outperfor
enGene Therapeutics Inc. (Nasdaq: ENGN, âenGeneâ or the âCompanyâ), a clinical-stage, non-vi
EXPD, VNCE, UCTT, PRG and TNET have been added to the Zacks Rank #1 (Strong Buy) List on June 8, 202
Further positive results from the Phase III SERENA-6 trial showed AstraZeneca's camizestrant plus a
Wells Fargo analyst John Kilichowski maintains Healthcare Realty Trust (NYSE:HR) with a Equal-Wei
Summit Therapeutics Inc. (NASDAQ: SMMT) today announced positive overall survival (OS) results from
[url="]Exelixis, Inc.[/url] (Nasdaq: EXEL) today announced results from a subgroup analysis of the p
Healthcare Realty Trust is well positioned in the outpatient medical REIT space, benefiting from mac
AstraZeneca and Daiichi Sankyo's ENHERTUÂ (fam-trastuzumab deruxtecan-nxki) has been approved by the
H&R Real Estate Investment Trust (HR.UN:CA) Q1 2026 Earnings Call Transcript
RBC Capital analyst Michael Carroll maintains Healthcare Realty Trust (NYSE:HR) with a Sector Per
D2L Survey Reveals How AI is Beginning to Reshape Entry-Level Work and the Talent Pipeline PR Newswi
Scotiabank analyst Nicholas Yulico maintains Healthcare Realty Trust (NYSE:HR) with a Sector Outp
Citigroup analyst Nick Joseph maintains Healthcare Realty Trust (NYSE:HR) with a Neutral and rais
NASHVILLE, Tenn., May 05, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE: HR) (
Cantor Fitzgerald analyst Richard Anderson maintains Healthcare Realty Trust (NYSE:HR) with a Ove
Healthcare Realty Trust Incorporated (NYSE:HR) ("Healthcare Realty") today announced that it
NASHVILLE, Tenn., May 04, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE: HR) (
U.S. equity markets advanced for a fifth straight week - their longest winning streak since 2024 - a
Healthcare Realty Trust Incorporated (HR) Q1 2026 Earnings Call Transcript
Healthcare Realty Trust (NYSE:HR) raises FY2026 FFO guidance from $1.58-$1.64 to $1.59-$1.65 vs $0.2
Healthcare Realty Trust (NYSE:HR) reported quarterly earnings of $0.41 per share. This is a 5.13 per
NASHVILLE, Tenn., April 30, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR)
UBS initiates coverage on Healthcare Realty Trust (NYSE:HR) with a Neutral rating and announces Pr
Cantor Fitzgerald analyst Richard Anderson maintains Healthcare Realty Trust (NYSE:HR) with a Ove
Healthcare Realty Trust (NYSE:HR) reported quarterly earnings of $0.40 per share. This is unchanged
Healthcare Realty Trust Incorporated (NYSE:HR) ("Healthcare Realty" or the "Company"
Wells Fargo analyst John Kilichowski maintains Healthcare Realty Trust (NYSE:HR) with a Equal-Wei
Healthcare Realty Trust (NYSE:HR) reported quarterly sales of $297.765 million which beat the analys
Wells Fargo analyst John Kilichowski upgrades Healthcare Realty Trust (NYSE:HR) from Underweight
RBC Capital analyst Michael Carroll initiates coverage on Healthcare Realty Trust (NYSE:HR) with